Individual with Upper Back Pain from Myofascial Pain Syndrome Myofascial Pain Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Presence of upper back pain located in the region extending from the posterior neck at the Superior Nuchal Line to the spinous process of the first thoracic vertebra (T1). 2. Presence of at least one trigger point in the upper trapezius muscle. The trigger point must demonstrate focal tenderness and pain recognition, meaning that the participant can recognize both the sensation and location of the pain (Chatchawan et al., 2005). 3. Presence of chronic pain lasting longer than 3 months (12 weeks). 4. Pain intensity ranging from 3 to 6 cm on the Visual Analogue Scale (VAS). Age between 18 and 65 years. 5. Voluntary participation in the study and provision of written informed consent.
Exclusion criteria
Exclusion criteria: 1. Acute pain, chronic secondary musculoskeletal pain, chronic cancer-related pain, or chronic neuropathic pain. 2. History of cardiovascular disease, cerebrovascular disease, liver disease, kidney disease, hematological disorders, diabetes mellitus, or infectious diseases. 3. History of tuberculosis, rheumatoid arthritis, ankylosing spondylitis, gout, or bone metastasis. 4. Presence of degenerative or herniated intervertebral discs and/or symptoms of pain, numbness, radiating pain, or weakness in the upper or lower extremities. 5. Individuals with contraindications to massage therapy and skin scraping techniques, including open wounds or skin diseases at the areas to be massaged or treated with hot stones, fever, active cancer or cancer currently under treatment, low blood pressure, high blood pressure, or symptoms of dizziness or lightheadedness. 6. History of psychiatric disorders or communication impairments. 7. History of peripheral sensory dysfunction. 8. Pregnancy, breastfeeding, or planning to become pregnant. 9. Planned surgery within the next 3 months. 10. History of allergy or adverse reaction to any treatment used in this study. 11. Use of analgesic medications or receipt of other pain treatments within the previous week. 12. Bleeding disorders or current use of antiplatelet or anticoagulant medications. 13. Enlarged lymph nodes. 14. Allergy to coconut oil. 15. Impaired hot or cold sensory perception. (Participants will be seated while the examiner uses one glass tube containing hot water and another containing cold water or ice water . The side of each tube will be gently applied to the skin at the upper arm, back, and thigh. The examiner will randomly alternate between the hot and cold tubes without allowing the participant to anticipate the stimulus. Each application will last no longer than 2 seconds. Participants who are able to correctly distinguish between hot and cold sensations will be considered to have normal thermal sensation )
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity before the intervention, at the end of intervention period, and six weeks after the intervention period will be measured using visual analog scale | — |
Secondary
| Measure | Time frame |
|---|---|
| pressure pain threshold before the intervention, at the end of intervention period, and six weeks after the intervention period will be measure using algometry,neck lateral flexion range of motion before the intervention, at the end of intervention period, and six weeks after the intervention period will be using cervical rage of motion goniometer,anxiety before the intervention, at the end of intervention period, and six weeks after the intervention period will be using state anxiety inventory questionnaire,sleep quality before the intervention, at the end of intervention period, and six weeks after the intervention period will be measure using The Pittsburgh Sleep Quality Index | — |
Countries
Thailand
Contacts
Mae Fah Luang University